" /> GHRH(1-29)NH2, PhAcTyr(1)-Arg(2)-P(H)e(4-CL)(6)-Ala(8)-Tyr(Me)(10)-His(11)-Abu(15)-His(20)-Nle(27)-Arg(28)-HLCr(29)- - CISMeF





Preferred Label : GHRH(1-29)NH2, PhAcTyr(1)-Arg(2)-P(H)e(4-CL)(6)-Ala(8)-Tyr(Me)(10)-His(11)-Abu(15)-His(20)-Nle(27)-Arg(28)-HLCr(29)-;

MeSH note : an antineoplastic agent;

CISMeF synonym : JMR 132;

MeSH synonym : 1-PhAcTyr-2,28-Arg-6-P(H)e(4-CL)-8-Ala-9-Har-10-Tyr(Me)-11,20-His-15-Abu-27-Nle-29-HLCr-GHRH(1-29)nh2; GHRH(1-29)NH2, phenylacetyltyrosyl(1)-arginyl(2)-P(H)e(4-CL)-alanyl(8)-homoarginyl(9)-O-methyltyrosyl(10)-histidyl(11)-alpha-aminobutyryl(15)-histidyl(20)-norleucyl(27)-arginyl(28)-HLCr(29)-;

MeSH hyponym : JMR132; JMR-132;

Is substance : O;

Details


You can consult :


Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.